National Institutes of Health
Impact of the Microbiome-Gut-Brain Axis on Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Not Allowed)
(PAR-22-211)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): October 05, 2022
Network for Personalization of Diagnostic Tests for Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional)
(RFA-AG-23-032)
National Institute on Aging
Application Receipt Date(s): October 17, 2022
Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)
(RFA-AG-23-033)
National Institute on Aging
Application Receipt Date(s): October 21, 2022
New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed)
(RFA-ES-22-006)
National Institute of Environmental Health Sciences
Application Receipt Date(s): November 08, 2022
HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 – Clinical Trial Optional)
(RFA-DA-23-045)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): February 02, 2023
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
(RFA-AG-23-029)
National Institute on Aging
Application Receipt Date(s): February 17, 2023
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
(RFA-AG-23-030)
National Institute on Aging
Application Receipt Date(s): February 17, 2023
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
(RFA-TR-22-030)
National Center for Advancing Translational Sciences
National Institute of Mental Health
Application Receipt Date(s): July 15, 2024
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
(PAR-22-209)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Application Receipt Date(s): October 17, 2024
Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
(PAS-22-196)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): September 05, 2025
Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
(PAS-22-197)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): September 05, 2025
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
(PAR-22-213)
National Institute on Aging
Application Receipt Date(s): September 25, 2025
National Science Foundation
Research Experiences for Undergraduates (REU) (NSF 22-601)
Full proposal deadline: September 6, 2022
Mid-Career Advancement (MCA) (NSF 22-603)
Submission window: February 1, 2023-March 1, 2023